Key result
Patients with limb girdle muscular dystrophy 2I exhibited reduced peak cardiac torsion compared to matched controls despite preserved strain.
Why the study?
What are the mechanisms of cardiac dysfunction in patients with limb girdle muscular dystrophy 2I compared to matched controls?
Case-Control (n=20)
What are the mechanisms of cardiac dysfunction in patients with limb girdle muscular dystrophy 2I compared to matched controls?
Patients with limb girdle muscular dystrophy 2I exhibit a unique pattern of cardiac dysfunction characterized by loss of torsion and reduced energetics despite preserved circumferential and longitudinal strain, suggesting subepicardial dysfunction.
Answers are grounded in this paper and cite their sources.
May indicate subepicardial dysfunction in LGMD2I; hypothesis-generating for torsion imaging, needing prospective validation.
AIM: The mechanisms of cardiac dysfunction in limb girdle muscular dystrophy 2I (LGMD2I) are unclear. This study assessed deficits in cardiac morphology, function, and metabolism quantitatively in patients with a confirmed genetic diagnosis of the homozygous c.826C > A FKRP (fukutin-related protein) mutation, using a comprehensive magnetic resonance (MR) examination. METHODS AND RESULTS: Ten patients (7 male and 3 female) and 10 matched control subjects were recruited prospectively. Cardiac morphology by cine imaging, cardiac torsion and strain by MR tagging, and cardiac energetics by phosphorus-31 MR spectroscopy were measured. LGMD2I subjects were found to have a significant reduction in peak cardiac torsion (3.9 ± 1.3° vs. 6.4 ± 1.5°, P = 0.04), and in the ratio of torsion to endocardial strain (0.31 ± 0.05 vs. 0.51 ± 0.14, P = 0.03), compared with control subjects. The impairment in torsion correlated strongly with reduction in EF (r = 0.93, P < 0.001). Peak circumferential and longitudinal strains were preserved in the patients, however [LGMD2I, 16.4 ± 3.2% vs. 18.3 ± 3.5%, non-significant (NS); and LGMD2I, 17.0 ± 3.0% vs. 18.4 ± 3.5%, NS]. Cardiac cine analysis demonstrated reduced EF (47 ± 7% vs, 58 ± 4%, P = 0.02) and stroke volume (61 ± 11 mL vs. 81 ± 13 mL, P = 0.04), though no evidence of LV hypertrophy was found. The ratio of phosphocreatine to ATP (PCr/ATP) was reduced in the LGMD2I subjects compared with controls (1.50 ± 0.24 vs. 1.94 ± 0.12, P = 0.0001). CONCLUSIONS: The loss of torsion with preservation of circumferential and longitudinal strain in LGMD2I is a unique finding and suggests subepicardial dysfunction with abnormal transmission of force across the cardiac wall.
No takes yet. Share an insight, caveat, or question.
Hollingsworth et al. (2013) conducted a case-control in Limb girdle muscular dystrophy 2I (LGMD2I) (n=20). Limb girdle muscular dystrophy 2I (LGMD2I) vs. Matched control subjects was evaluated on Peak cardiac torsion (degrees) (p=0.04). Patients with limb girdle muscular dystrophy 2I exhibited reduced peak cardiac torsion compared to matched controls despite preserved strain.
Synapse has enriched 10 related papers. Consider them for comparative context: